BeiGene Ltd (BGNE)
171.03
+6.15
(+3.73%)
USD |
NASDAQ |
May 16, 16:00
171.02
-0.01
(-0.01%)
After-Hours: 20:00
BeiGene 1 Year Total Returns (Daily): -28.41% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | -28.41% |
May 15, 2024 | -31.37% |
May 14, 2024 | -32.55% |
May 13, 2024 | -31.97% |
May 10, 2024 | -34.27% |
May 09, 2024 | -31.36% |
May 08, 2024 | -35.24% |
May 07, 2024 | -35.72% |
May 06, 2024 | -34.95% |
May 03, 2024 | -38.77% |
May 02, 2024 | -38.50% |
May 01, 2024 | -39.79% |
April 30, 2024 | -39.62% |
April 29, 2024 | -38.61% |
April 26, 2024 | -37.58% |
April 25, 2024 | -39.80% |
April 24, 2024 | -44.01% |
April 23, 2024 | -46.22% |
April 22, 2024 | -49.34% |
April 19, 2024 | -49.90% |
April 18, 2024 | -50.54% |
April 17, 2024 | -50.20% |
April 16, 2024 | -49.22% |
April 15, 2024 | -47.58% |
April 12, 2024 | -44.56% |
Date | Value |
---|---|
April 11, 2024 | -42.00% |
April 10, 2024 | -36.27% |
April 09, 2024 | -35.41% |
April 08, 2024 | -37.20% |
April 05, 2024 | -29.23% |
April 04, 2024 | -30.43% |
April 03, 2024 | -28.62% |
April 02, 2024 | -28.90% |
April 01, 2024 | -26.12% |
March 28, 2024 | -28.90% |
March 27, 2024 | -31.01% |
March 26, 2024 | -29.99% |
March 25, 2024 | -29.94% |
March 22, 2024 | -29.51% |
March 21, 2024 | -27.52% |
March 20, 2024 | -23.95% |
March 19, 2024 | -24.73% |
March 18, 2024 | -24.55% |
March 15, 2024 | -27.95% |
March 14, 2024 | -26.98% |
March 13, 2024 | -20.59% |
March 12, 2024 | -24.27% |
March 11, 2024 | -23.91% |
March 08, 2024 | -30.38% |
March 07, 2024 | -29.92% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-65.47%
Minimum
Oct 11 2022
182.7%
Maximum
Mar 31 2021
15.90%
Average
12.87%
Median
Feb 26 2020
1 Year Total Returns (Daily) Benchmarks
Theravance Biopharma Inc | -13.59% |
LumiraDx Ltd | -96.08% |
Dr Reddy's Laboratories Ltd | 26.64% |
ASLAN Pharmaceuticals Ltd | -90.18% |
Jazz Pharmaceuticals PLC | -15.68% |